InvestorsHub Logo
Followers 4
Posts 716
Boards Moderated 0
Alias Born 09/07/2018

Re: hobbyjack post# 17176

Tuesday, 04/30/2019 11:59:01 AM

Tuesday, April 30, 2019 11:59:01 AM

Post# of 69659
1) Tweet 3/22: Link to interview with the Big Biz Show ( )
2) PR & Tweet 3/18: February revenues and Business Update ( )
3) Tweet 3/26: CBD Oil product label revealed ( )
4) PR & Tweet 3/27: INND signs DTC Agreement with SEARS ( )
5) PR & Tweet 4/3: INND signs DTC Agreement with KMART ( )
6) Tweet 4/3: CEO Matthew Moore on the Big Biz Show - (
)
7) Tweet 4/4: Official mockup of INND CBD Oil ( )
8) Tweet 4/8: Official mockup of INND Hearing Supplements! ( )
9) PR & Tweet 4/9: WALMART to carry INND Hearing Supplements! ( )
10) Tweet 4/9: Link to interview with the Big Biz Show ( )
11) PR & Tweet 4/10: Unaudited revenues of 758% from Q1 2019 over Q1 2018! ( )
12) PR & Tweet 4/23: INND Partners with Shark Tank shark KEVIN HARRINGTON! ( )
13) PR & Tweet 4/30: Clinics #8 (Santa Rosa) and #9 (Pleasanton) are open! ( )

MORE TO COME!


14) PR & Tweet Early May: Proprietary CBD Oil and Nutritional Hearing Dietary Supplements Product Lineup Introduction to the Retail Market
15) PR & Tweet May: Reveal of the Nexus and other Global Retailers
16) Multiple PR's & Tweet's mid to late May: Opening clinics #10 AND #11
17) Multiple PR's & Tweets June/July/August: Opening clinics #12-#22!!!

THIS SUMMER!

18) FDA-Approval for the WORLD'S FIRST EVER LASER TREATMENT FOR TINNITUS
///(there is currently no known treatment for tinnitus - only devices that mask or provide temporary relief)

So far in 2019 we've seen the following:
January 2019 outperformed January 2018 by 524%
Q4 2018 outperformed Q3 2018 by 281%.
February 2019 outperformed February 2018 by 551%
February outperformed January by 143%
Q1 2019 outperformed Q1 2018 by 758%

Innerscope Hearing Technologies received an award from Global Health & Pharma (GHP) for the 2019 BEST HEARING AID MANUFACTURER IN THE USA ( )

Barchart.com gives Innerscope a 96% BUY RATING on https://www.barchart.com/stocks/quotes/INND/opinion

Historical Earnings Report Submissions:
In 2019 Innerscope filed NT-10K and submitted on April 16 (https://www.sec.gov/Archives/edgar/data/1609139/000155479519000105/innd0416form10k.htm)
In 2018 Innerscope filed NT-10K and submitted on April 17
In 2017 Innerscope filed on March 31 (on time)

2019 10-Q for Quarterly Period Ended 03/31/19 due Wednesday, May 15, 2019 COMING SOON!
In 2018 Innerscope filed Q1's NT-10Q on May 16 and submitted on May 25
In 2017 Innerscope filed Q1's NT-10Q on May 15 and submitted on May 22

NEW Shareholder Letter - https://www.sec.gov/Archives/edgar/data/1609139/000155479519000107/innd0417form8k.htm

Keep in mind the Compound Annual Growth Rate (CAGR) of the Hearing Aid Industry is expected to increase 4% annually until 2026
(https://thefinancialstrategy.com/global-hearing-aids-market-scenario-cagr-of-4-in-terms-of-value-during-2017-2026/)

Innerscope is getting GREAT response from Big Box Retailers on their Doctor-Formulated Hearing & Tinnitus Nutritional Supplements. Innerscope is looking to be in dozens of BIG BOX Retailers this year. NOTE: Pre-order sales have already been booked and their oils/supplements aren't even available until the end of April.

IMO, it's highly likely that other major retailers will be announced in May as well. Companies like CVS, Walgreens, Target, Costco, and Rite-aid are ON DECK!

Additionally, signs of the global hearing community tuning into Innerscope are also becoming apparent. For example, the Association for People Affected by Tinnitus (APAT) in Barcelona, Spain - a highly active support group and advocate for which provides discussion forums and resources for people who struggle with tinnitus are following Innerscope on Twitter. Here is the text from their Goals page (this text has been translated from Spanish to English using Google Translate):


From its foundation until today, the main objective of APAT has been to attend, inform and help those affected go to the Association in search of solutions and mitigating measures on their ailment. This care for those affected is provided in person at the social premises of APAT, by postal and computer mail and by telephone.

To assist the affected people we have a helpline 699067743 attended by volunteers with sufficient preparation for this, an email address: jims@es.inter.net and, the postal address: Carrer Providéncia, 42; 08024 Barcelona. Face-to-face attendance takes place every Wednesday from 18:00 to 20:00 hours, and on days and times agreed by telephone.

We have the advice of various professionals: otolaryngologist, neurologist and psychologist.

People affected by tinnitus usually go through a ordeal that begins with a visit to their GP, which leads them to the ENT, or going directly to the ENT. Unfortunately, in many cases the otorrino has no solution for a problem whose origin can not diagnose, and sometimes ends up explaining to the patient that he must live with his tinnitus, and at other times it is the patient who reaches the conclusion . At this time, the patient is disoriented and, in many cases, the accumulated anxiety over time waiting for a solution of the otorrino, becomes depression. It is at this moment in the process when the intervention of the APAT volunteers can inform and help the affected person to overcome, to explore other possibilities and, in any case,

APAT members receive a quarterly magazine in which they are informed about new treatments, palliative measures, advances in pharmacology applied to tinnitus, etc. They are also invited to thematic conferences on aspects of the disease that are organized on 2 or 3 occasions a year. The association also manages a mutual aid group that meets monthly in Barcelona for free and non-exclusive assistance for members.

APAT has tried to get these mutual aid groups to meet in other Spanish cities, for which it is necessary that there be an initiative and continuity on the part of affected people living in such cities. On three occasions these groups have started in as many Spanish cities, without, for the moment, having had continuity. However, APAT will collaborate in any initiative that exists in that sense.